tetradecanoylphorbol acetate has been researched along with armepavine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CF; Kuo, YC; Liao, JF; Lin, YL; Liu, CP; Shen, CC; Tsai, WJ; Wu, MH | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and armepavine
Article | Year |
---|---|
(S)-armepavine inhibits human peripheral blood mononuclear cell activation by regulating Itk and PLCgamma activation in a PI-3K-dependent manner.
Topics: Alkaloids; Benzylisoquinolines; Calcimycin; Calcium; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Interferon-gamma; Interleukin-2; Leukocytes, Mononuclear; Molecular Conformation; Molecular Weight; Nelumbo; NF-kappa B; NFATC Transcription Factors; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phospholipase C gamma; Phosphorylation; Protein Kinase C; Protein-Tyrosine Kinases; RNA, Messenger; Seeds; Structure-Activity Relationship; Tetradecanoylphorbol Acetate | 2007 |